Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.6950 (2.64%) ($40.6950 - $40.6950) on Thu. Sep. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.76% (three month average) | RSI | 47 | Latest Price | $40.6950(2.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.5% a day on average for past five trading days. | Weekly Trend | HALO declines -1.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(49%) IWM(48%) IWC(44%) IWN(44%) | Factors Impacting HALO price | HALO will decline at least -0.88% in a week (0% probabilities). VIXM(-28%) VXX(-10%) UUP(-10%) TBT(-2%) GLD(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.88% (StdDev 1.76%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $35.67(-12.35%) | Resistance Level | $41.24 | 5 Day Moving Average | $39.87(2.07%) | 10 Day Moving Average | $40.7(-0.01%) | 20 Day Moving Average | $41.24(-1.32%) | To recent high | -12.3% | To recent low | 6.3% | Market Cap | $5.562b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |